Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print

Latest Articles in sun pharma

Sun Pharma's Board Aprroves Share Buyback Worth Rs 1,700 Cr

Shares of Sun Pharmaceutical Industries were trading at Rs 380.70 per scrip on BSE, up 3.23 per cent from its previous close.

Read More

India's Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

The U.S. Food and Drug Administration announced the first coronavirus-related drug shortage in the United States but declined to name the drug in question.

Read More

Sensex Ends 182 Points Higher; RIL Up 2 Per Cent

After scaling a lifetime (intra-day) high of 40,816.38, the 30-share index ended 181.94 points or 0.45 per cent, higher at 40,651.64.

Read More

Sun Pharma: Global Is Local

‘We are meticulously nurturing the specialty business and have built a portfolio of about 10 specialty products’

Read More

Sun Pharma Tumbles After Report Of Probe

Markets regulator Securities and Exchange Board of India (SEBI) is likely to reopen an insider trading case against Sun, media sources reported

Read More

Sensex Rebounds On Value-Buying In Beaten Down Stocks, RIL Leads Recovery

BSE Sensex recovered at 224.50 points to end at 38,242.81 on value buying in hammered stocks led by RIL and Sun Pharma

Read More

The Fight Is On

Sun Pharma’s Dilip Shanghvi is all set to conquer the new normal

Read More

Market Moves With Caution, RBI Rate Call Takes Centre-stage

Major stocks that rose include Sun Pharma, PowerGrid, Dr Reddy's and RIL, jumping up to 3.47 per cent

Read More

Liquidity Worries Haunt Stocks, Sensex, Nifty Stay Soft

The mood at the outset was one of bullishness, given a gap-up opening, but bears took charge during the last half an hour of trade

Read More

Sun Pharma Reports Quarterly Loss After One-off Charge

The net loss was 4.25 billion rupees ($66 million) in the three months ending on June 30, compared with a profit of 20.34 billion rupees a year earlier

Read More

No More Freebies: India Plans Crackdown On Marketing By Drugmakers

While such rules are common elsewhere in the world and adhered to by large pharmaceutical companies, they are not set in stone in India, where campaigners have long demanded a crackdown on unethical selling practices

Read More

Is It The End Of Pharma’s Dream Run?

Unless the Indian pharma industry — not long ago touted as the pharmacy of the world — strives to be more than just a plain generics player

Read More

Worst Ever Quarter For Indian Pharma

Top drug makers such as Sun Pharmaceutical Industries, Dr Reddy’s Laboratories and Cadila Healthcare faced US import ban on their key production facilities in India

Read More

Sun Pharma Buys Novartis’ Anti-cancer Brand Odomzo For $175 Million

Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed

Read More

Sun Pharma Buys Russian Drug Maker JSC Biosintez

JSC is currently engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region mainly focusing on the hospital segment had annual revenues of approximately $ 52 million in 2015

Read More